Literature DB >> 21266521

Menopausal hormone therapy does not influence lung cancer risk: results from the California Teachers Study.

Jessica Clague1, Peggy Reynolds, Jane Sullivan-Halley, Huiyan Ma, James V Lacey, Katherine D Henderson, Giske Ursin, Dee West, Shine Chang, George L Delclos, Xianglin L Du, Michele R Forman, Leslie Bernstein.   

Abstract

BACKGROUND: Results from studies examining the association between hormone therapy (HT) and lung cancer risk disagree.
METHODS: We examined the associations between HT use and lung cancer risk among 60,592 postmenopausal women enrolled in the prospective California Teachers Study cohort. Between 1995 and 2007, a total of 727 women had a diagnosis of lung cancer. Multivariable Cox proportional hazards regression models were fit using age as the time metric.
RESULTS: No measure of HT use was associated with lung cancer risk (all P(trend) values ≥0.4). In addition, no variations in risk by smoking status (never, ever, former, current), type of HT [estrogen (E)-alone, E + progestin (P) use], type of menopause, or lung cancer histology were observed.
CONCLUSIONS: Our findings do not support an association between HT and lung cancer. IMPACT: This large-scale, prospective study, which capitalizes on the detailed hormone use, smoking history, and type of menopause information available within this unique cohort, was unable to find any association between intake of HT and lung cancer risk. ©2011 AACR.

Entities:  

Mesh：

Year:  2011        PMID： 21266521      PMCID： PMC3065239          DOI： 10.1158/1055-9965.EPI-10-1182

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


  5 in total

1.  High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States).

Authors:  Leslie Bernstein; Mark Allen; Hoda Anton-Culver; Dennis Deapen; Pamela L Horn-Ross; David Peel; Richard Pinder; Peggy Reynolds; Jane Sullivan-Halley; Dee West; William Wright; Al Ziogas; Ronald K Ross
Journal:  Cancer Causes Control       Date:  2002-09       Impact factor: 2.506

Review 2.  Menopausal hormone therapy and risk of lung cancer-Systematic review and meta-analysis.

Authors:  Claudia M Greiser; Eberhard M Greiser; Martina Dören
Journal:  Maturitas       Date:  2009-12-23       Impact factor: 4.342

Review 3.  Hormone therapy and risk of lung cancer: a meta-analysis.

Authors:  Seung Won Oh; Seung-Kwon Myung; Ji Young Park; Youl Lee Lym; Woong Ju
Journal:  J Womens Health (Larchmt)       Date:  2010-02       Impact factor: 2.681

Review 4.  Lung cancer in women: emerging differences in epidemiology, biology, and therapy.

Authors:  Leno Thomas; L Austin Doyle; Martin J Edelman
Journal:  Chest       Date:  2005-07       Impact factor: 9.410

Review 5.  Lung cancer in never smokers: a review.

Authors:  Janakiraman Subramanian; Ramaswamy Govindan
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544
  5 in total
  16 in total

1.  Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort.

Authors:  Louise A Brinton; Lauren Schwartz; Margaret R Spitz; Yikyung Park; Albert R Hollenbeck; Gretchen L Gierach
Journal:  Cancer Causes Control       Date:  2012-02-25       Impact factor: 2.506

2.  Hormone Use, Reproductive History, and Risk of Lung Cancer: The Women's Health Initiative Studies.

Authors:  Ann G Schwartz; Roberta M Ray; Michele L Cote; Judith Abrams; Robert J Sokol; Susan L Hendrix; Chu Chen; Rowan T Chlebowski; F Allan Hubbell; Charles Kooperberg; JoAnn E Manson; Mary Jo O'Sullivan; Thomas Rohan; Marcia L Stefanick; Jean Wactawski-Wende; Heather Wakelee; Michael S Simon
Journal:  J Thorac Oncol       Date:  2015-07       Impact factor: 15.609

Review 3.  Smoking out reproductive hormone actions in lung cancer.

Authors:  Jill M Siegfried
Journal:  Mol Cancer Res       Date:  2014-01-07       Impact factor: 5.852

4.  Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort.

Authors:  Louise A Brinton; Gretchen L Gierach; Abegail Andaya; Yikyung Park; Arthur Schatzkin; Albert R Hollenbeck; Margaret R Spitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-05       Impact factor: 4.254

Review 5.  Lung cancer chemoprevention: current status and future prospects.

Authors:  Robert L Keith; York E Miller
Journal:  Nat Rev Clin Oncol       Date:  2013-05-21       Impact factor: 66.675

6.  Reproductive and hormonal factors and the risk of lung cancer: the EAGLE study.

Authors:  Angela Cecilia Pesatori; Michele Carugno; Dario Consonni; Neil E Caporaso; Sholom Wacholder; Margaret Tucker; Maria Teresa Landi
Journal:  Int J Cancer       Date:  2012-11-26       Impact factor: 7.396

7.  Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO).

Authors:  A C Pesatori; M Carugno; D Consonni; R J Hung; A Papadoupolos; M T Landi; H Brenner; H Müller; C C Harris; E J Duell; A S Andrew; J R McLaughlin; A G Schwartz; A S Wenzlaff; I Stucker
Journal:  Br J Cancer       Date:  2013-09-03       Impact factor: 7.640

8.  Hormone replacement therapy in females can decrease the risk of lung cancer: a meta-analysis.

Authors:  Yanwen Yao; Xiaoling Gu; Juehua Zhu; Dongmei Yuan; Yong Song
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

9.  Lung cancer in never smokers in the UK Million Women Study.

Authors:  Kirstin Pirie; Richard Peto; Jane Green; Gillian K Reeves; Valerie Beral
Journal:  Int J Cancer       Date:  2016-03-31       Impact factor: 7.396

Review 10.  Hormonal Replacement Therapy and the Risk of Lung Cancer in Women: An Adaptive Meta-analysis of Cohort Studies.

Authors:  Jong-Myon Bae; Eun Hee Kim
Journal:  J Prev Med Public Health       Date:  2015-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.